Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial
tumours, which tend to recur but are generally not life threatening, and 30% presenting as …

CONTEXT: This review focuses on the prediction of recurrence and progression in non–
muscle invasive bladder cancer (NMIBC) and the treatments advocated for this disease …

OBJECTIVES: To provide tables that allow urologists to easily calculate a superficial bladder
cancer patient's short-and long-term risks of recurrence and progression after transurethral …

Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …

CONTEXT: The natural history of renal cell carcinoma (RCC) is highly unpredictable. Small
renal masses may be accompanied by metastatic disease. Conversely, patients with locally …

Objectives With the advent of novel genomic and transcriptomic technologies, new urinary
biomarkers have been identified and tested for bladder cancer (BCa) surveillance. To …

Transitional cell (urothelial) carcinoma of the bladder is the second most common urologic
malignancy and is one of the best understood neoplasms, with relatively well-defined …

Objective The aim of this study was to summarize and analyze the current evidence
regarding the prognostic and predictive value of preoperative neutrophil-to-lymphocyte ratio …

Urine cytology is the most widely used noninvasive test to detect urothelial tumors. However,
it is limited by its low sensitivity. On the other hand, cystoscopy is the gold standard …

For evaluation of the “Long-Term Clinical and Biochemical Follow-Up in Medullary Thyroid
Carcinoma,” Cupisti et al1 collapsed 127 patients with initial neck surgery (including 12 …